← boothcheck

MOH vs OSCR stock comparison

MOLINA HEALTHCARE, INC. vs Oscar Health, Inc., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Molina administers Medicaid, revenue by state contract; Oscar sells individual-market plans, revenue by exchange enrollment, and the two business models are currently failing in opposite directions: Molina's margins compressed to a 0.42% net by rate resets it cannot control, Oscar's 15.2% operating margin nets negative on a model still proving itself. Neither has an earnings multiple. Molina carries 0.92 turns of debt, Oscar 0.26; Oscar's 28.5% free-cash figure is float. The market values them within $2B of each other, $12B and $10B, an incumbent at its cyclical worst priced like a challenger at its structural midpoint. Both prices are bets on normalization; only one company has ever seen normal.

Comparison updated 2026-07-10.

MOH vs OSCR: the numbers

MetricMOHOSCR
Price$229.88$29.79
Market cap$11.7B$9.8B
SectorManaged CareManaged Care
StageMatureGrowth
P/B2.875.89
P/S0.260.74
EV/EBITDA16.5309.2
Revenue growth+8.0%+30.5%
Operating margin0.8%15.2%
Net margin0.4%-0.3%
Return on equity4.6%-2.4%
Return on assets1.1%-0.4%
Return on invested capital2.6%0.5%
FCF yield2.1%28.5%
Debt / equity0.920.26
Current ratio1.631.09
Altman Z (solvency)4.022.14
Piotroski F (quality)7 / 98 / 9
Full MOH report → Full OSCR report →
Get boothcheck's read on MOH and OSCR, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.